FCGR3A and neoplasm: Our observations revealed the presence of CD56 and/or CD16-positive NK cells (indicated by red arrows in Figure 1C) in the junctional zone between clusters of cancer cells and the area of cancer cell lysis in the MUC1-expressing xenograft tumor tissue, as well as in the liver and lung.